bluesail+

Medical Devices & EquipmentSeries BBeijing, China

Latest round

Series B

Last raised

Sep 2026

Total raised

$244M

Investors

5

About bluesail+

, trading as bluesail+, operates as a medical device developer dedicated to providing cardiovascular and cerebrovascular treatment equipment. It is a subsidiary of Bluesail Medical. The company integrates entities such as Singapore-based Biosensors International Group (including China’s JW Medical), Germany’s NVT, and the Bluesail Shanghai R&D Center. The company's main business is the research, development, production and sales of cardiac stents. Its products include coronary artery graft intervention, valve replacement and repair systems, etc. The products are mainly used to treat cardiovascular and cerebrovascular diseases. The company generates revenue by providing medical devices used to treat cardiovascular and cerebrovascular diseases, such as heart stents, and other related products.

Who invested in bluesail+

5 investors across 3 rounds

See all investors in bluesail+

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 23, 2026

    Amount

    $104M

    Investors

    Locked

  2. Series A

    May 21, 2024

    Amount

    $14M

    Investors

    Locked

  3. Series A

    Jan 26, 2024

    Amount

    $126M

    Investors

    Locked

Questions about bluesail+

Who invested in bluesail+?

bluesail+ has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has bluesail+ raised?

bluesail+ has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did bluesail+ last raise money?

bluesail+'s most recent round on record is a Series B, in Sep 2026.

What does bluesail+ do?

, trading as bluesail+, operates as a medical device developer dedicated to providing cardiovascular and cerebrovascular treatment equipment.

Where is bluesail+ headquartered?

bluesail+ is headquartered in Beijing, China.

Which VCs invest in companies like bluesail+?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at bluesail+'s stage. Their profiles are linked below.

Raising like bluesail+? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.